
October to December 2022
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| MOLNUPIRAVIR | $250,391,504 | 225,318 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $128,102,954 | 5,997 |
| NIRMATRELVIR (&) RITONAVIR | $124,189,133 | 108,695 |
| AFLIBERCEPT | $119,657,111 | 112,638 |
| PEMBROLIZUMAB | $113,462,732 | 13,409 |
| NIVOLUMAB | $105,452,029 | 14,458 |
| USTEKINUMAB | $89,212,672 | 12,298 |
| APIXABAN | $84,315,118 | 994,245 |
| ADALIMUMAB | $76,589,236 | 85,179 |
| DENOSUMAB | $72,680,436 | 287,922 |
| LENALIDOMIDE | $64,631,410 | 11,742 |
| DUPILUMAB | $63,907,482 | 37,394 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $35,369,629 | 4,310,247 |
| ATORVASTATIN | $29,500,805 | 3,219,146 |
| PANTOPRAZOLE | $25,222,274 | 2,716,339 |
| ESOMEPRAZOLE | $23,211,397 | 2,220,992 |
| PERINDOPRIL | $14,991,395 | 1,863,237 |
| METFORMIN | $15,650,493 | 1,629,478 |
| ESCITALOPRAM | $7,998,736 | 1,572,346 |
| SERTRALINE | $8,324,375 | 1,473,607 |
| CEFALEXIN | $7,929,931 | 1,416,372 |
| AMLODIPINE | $11,237,362 | 1,292,392 |
| TELMISARTAN | $8,937,408 | 1,184,334 |
| CANDESARTAN | $8,922,854 | 1,098,132 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,620,759,378 |
| Patients | $777,391,339 |